Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 16, 2009American Journal of Clinical Pathology

Peritumoral Activated Hepatic Stellate Cells Predict Poor Clinical Outcome in Hepatocellular Carcinoma After Curative Resection

View Full Paper
Ask AI
Bookmark
Share

Authors

MJMin‐Jie JuShanghai Medical College of Fudan UniversitySQShuang–Jian QiuCentral South UniversityJFJia FanHebei Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ju et al. (2009) studied this question.

synapsesocial.com/papers/6a0da38bfb8c7be8ffba7752https://doi.org/10.1309/ajcp86ppbngohnnl
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Adam12 in Human Liver Cancers: Tgf–β–Regulated Expression in Stellate Cells Is Associated With Matrix Remodeling2003 · 200 citations
  2. 2Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factor1997 · 151 citations
  3. 3ICAM‐1 expressed on hepatic stellate cells plays an important role in immune regulation2007 · 16 citations
  4. 4Proangiogenic Role of Tumor–Activated Hepatic Stellate Cells in Experimental Melanoma Metastasis2003 · 188 citations